Crystal Group Aligns Global Life Sciences Brands Under a Unified Identity

Crystal Pharmatech, Crystal Bio Solutions, and Crystal NAX to operate under the unified Crystal Group identity

Suzhou, China – June 16, 2026 — Crystal Group today announced a global brand alignment that unifies its operating companies under a single, cohesive identity. The initiative brings Crystal Pharmatech, Crystal Bio Solutions, and Crystal NAX together under the Crystal Group name, reflecting the way the organization operates today as one integrated life sciences platform.

As part of the initiative, each operating company is updating its branding to more clearly express its relationship to Crystal Group, while retaining the market position, scientific expertise, and service offerings it is known for.

The following LinkedIn Page name updates will take effect:

The update reflects Crystal Group's continued growth as a diversified life sciences organization serving pharmaceutical and biotechnology innovators across a range of therapeutic modalities.

A Unified Global Identity

Crystal Group has built a platform that brings together specialized, complementary capabilities across three operating companies:

• Small Molecule Development through Crystal Pharmatech

• Biologics Development through Crystal Bio Solutions

• Nucleic Acid Technologies through Crystal NAX

By bringing these capabilities under a common identity, the updated naming convention creates a clearer and more cohesive structure for clients, partners, and talent worldwide — without changing the teams, expertise, or services they rely on.

"This brand alignment reflects the way our businesses operate today," said Alex M. Chen, Co-founder, Chairman & Chief Executive Officer of Crystal Group. "Each division will continue to deliver its distinct scientific expertise while operating under the broader Crystal Group identity, united by a shared commitment to advancing innovative therapies for patients worldwide."

About Crystal Group

Crystal Group is a global life sciences organization supporting pharmaceutical and biotechnology innovators from early development through commercial manufacturing. Through its operating companies — Crystal Pharmatech (small molecule), Crystal Bio Solutions (biologics), and Crystal NAX (nucleic acid technologies) — Crystal Group delivers integrated capabilities across a broad range of therapeutic modalities.